Novel resveratrol-based substrates for human hepatic, renal, and intestinal UDP-glucuronosyltransferases

Chemical Research in Toxicology

Volumn 27, Issue 4, 2014, Pages 536-545

  Greer, Aleksandra K ^a   Madadi, Nikhil R ^b   Bratton, Stacie M ^a   Eddy, Sarah D ^a   Mazerska, Zofia ^a,c   Hendrickson, Howard P ^b   Crooks, Peter A ^b   Radominska Pandya, Anna ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIMETHOXY 6 (4 METHOXYSTYRYL)BENZALDEHYDE OXIME; 3 (3 HYDROXY 4 METHOXYPHENYL) 2 (3,4,5 TRIMETHOXYPHENYL)ACRYLIC ACID; 4 (3,5 DIMETHOXYSTYRYL) 2,6 DINITROPHENOL; AROMATIC COMPOUND; BETA GLUCURONIDASE; FUNCTIONAL GROUP; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A10; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A8; HYDROXYL GROUP; RECOMBINANT ENZYME; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; CONJUGATION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; METHYLATION; PROTEIN FAMILY; TANDEM MASS SPECTROMETRY; ENZYME SPECIFICITY; ENZYMOLOGY; INTESTINE; KIDNEY; LIVER; MASS SPECTROMETRY; METABOLISM; MICROSOME; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCURONOSYLTRANSFERASE; HUMANS; INTESTINES; KIDNEY; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICROSOMES; STILBENES; SUBSTRATE SPECIFICITY;

EID: 84899456661     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx400408x     Document Type: Article

References (24)

1. Aumont, V., Krisa, S., Battaglia, E., Netter, P., Richard, T., Merillon, J. M., Magdalou, J., and Sabolovic, N. (2001) Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human Arch. Biochem. Biophys. 393, 281-289
2. Sabolovic, N., Humbert, A. C., Radominska-Pandya, A., and Magdalou, J. (2006) Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells Biopharm. Drug Dispos. 27, 181-189
3. Baur, J. A. and Sinclair, D. A. (2006) Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discovery 5, 493-506
4. Patel, K. R., Brown, V. A., Jones, D. J., Britton, R. G., Hemingway, D., Miller, A. S., West, K. P., Booth, T. D., Perloff, M., Crowell, J. A., Brenner, D. E., Steward, W. P., Gescher, A. J., and Brown, K. (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients Cancer Res. 70, 7392-7399
5. Wenzel, E. and Somoza, V. (2005) Metabolism and bioavailability of trans-resveratrol Mol. Nutr. Food Res. 49, 472-481
6. Vitaglione, P., Sforza, S., Galaverna, G., Ghidini, C., Caporaso, N., Vescovi, P. P., Fogliano, V., and Marchelli, R. (2005) Bioavailability of trans-resveratrol from red wine in humans Mol. Nutr. Food. Res. 49, 495-504
7. Cottart, C. H., Nivet-Antoine, V., Laguillier-Morizot, C., and Beaudeux, J. L. (2010) Resveratrol bioavailability and toxicity in humans Mol. Nutr. Food. Res. 54, 7-16
8. Brill, S. S., Furimsky, A. M., Ho, M. N., Furniss, M. J., Li, Y., Green, A. G., Bradford, W. W., Green, C. E., Kapetanovic, I. M., and Iyer, L. V. (2006) Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms J. Pharm. Pharmacol. 58, 469-479
9. Brents, L. K., Medina-Bolivar, F., Seely, K. A., Nair, V., Bratton, S. M., Nopo-Olazabal, L., Patel, R. Y., Liu, H., Doerksen, R. J., Prather, P. L., and Radominska-Pandya, A. (2012) Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors Xenobiotica 42, 139-156
10. Argikar, U. A. (2012) Unusual glucuronides Drug. Metab. Dispos. 40, 1239-1251
11. Antonio, L., Xu, J., Little, J. M., Burchell, B., Magdalou, J., and Radominska-Pandya, A. (2003) Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7 Arch. Biochem. Biophys. 411, 251-261
12. Sabolovic, N., Heydel, J. M., Li, X., Little, J. M., Humbert, A. C., Radominska-Pandya, A., and Magdalou, J. (2004) Carboxyl nonsteroidal anti-inflammatory drugs are efficiently glucuronidated by microsomes of the human gastrointestinal tract Biochim. Biophys. Acta 1675, 120-129
13. Kurkela, M., Garcia-Horsman, J. A., Luukkanen, L., Morsky, S., Taskinen, J., Baumann, M., Kostiainen, R., Hirvonen, J., and Finel, M. (2003) Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme J. Biol. Chem. 278, 3536-3544
14. Kuuranne, T., Kurkela, M., Thevis, M., Schanzer, W., Finel, M., and Kostiainen, R. (2003) Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases Drug Metab. Dispos. 31, 1117-1124
15. Weiss, J. N. (1997) The Hill equation revisited: uses and misuses FASEB J. 11, 835-841
16. Fraga, C. G. (2007) Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions IUBMB Life 59, 308-315
17. Surh, Y. J., Kundu, J. K., Na, H. K., and Lee, J. S. (2005) Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals J. Nutr. 135, 2993S-3001S
18. Baur, J. A. and Sinclair, D. A. (2006) Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discovery 5, 493-506
19. Roberti, M., Pizzirani, D., Simoni, D., Rondanin, R., Baruchello, R., Bonora, C., Buscemi, F., Grimaudo, S., and Tolomeo, M. (2003) Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents J. Med. Chem. 46, 3546-3554
20. Lee, S. K., Nam, K. A., Hoe, Y. H., Min, H. Y., Kim, E. Y., Ko, H., Song, S., Lee, T., and Kim, S. (2003) Synthesis and evaluation of cytotoxicity of stilbene analogues Arch. Pharmacal Res. 26, 253-257
21. Piotrowska, H., Myszkowski, K., Ziolkowska, A., Kulcenty, K., Wierzchowski, M., Kaczmarek, M., Murias, M., Kwiatkowska-Borowczyk, E., and Jodynis-Liebert, J. (2012) Resveratrol analogue 3,4,4′,5- tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells Toxicol. Appl. Pharmacol. 263, 53-60
22. Borrel, C., Thoret, S., Cachet, X., Guenard, D., Tillequin, F., Koch, M., and Michel, S. (2005) New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation Bioorg. Med. Chem. 13, 3853-3864
23. Madadi, N. R. (2013) University of Arkansas for Medical Sciences, Little Rock, AR. Unpublished data.
24. Yong, Z. and Xu, X. (2009) Styrene-acid derivative and use in manufacturing blood-vessel targeted-agent drugs. PCT Int. Appl. WO2007CN03127 20071105.